BMJ 1994;309:1244-45 (12 November)

Editorials

Pulmonary emphysema

The treatment of advanced pulmonary emphysema is a serious and depressing problem for respiratory physicians. The patients, mainly smokers or former smokers, suffer from progressive disability and have a reduced life expectancy. Such patients are short of breath on mild exertion and have hyperresonant chests and quiet or absent breath sounds. Destruction of the alveolar walls is a key feature of the disease.1

Emphysema can be divided into pathological types according to the distribution of the enlarged air spaces within the acinus (the section of the lung that is supplied by a single terminal bronchiole2). Two types seem important. In the centriacinar form the enlarged air spaces are in the centre of the acinus close to the terminal bronchioles, and these lesions are usually situated in the upper zones of the lungs. In the panacinar form the whole acinus is affected and lesions may be distributed throughout the lung . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • KASAHARA, Y., TUDER, R. M., COOL, C. D., LYNCH, D. A., FLORES, S. C., VOELKEL, N. F. (2001). Endothelial Cell Death and Decreased Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor 2 in Emphysema. Am. J. Respir. Crit. Care Med. 163: 737-744 [Abstract] [Full text]  
Access jobs at BMJ Careers
Whats new online at Student BMJ